Functions of the DNA damage response pathway target Ho endonuclease of yeast for degradation via the ubiquitin-26S proteasome system.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMC 27699)

Published in Proc Natl Acad Sci U S A on August 29, 2000

Authors

L Kaplun1, Y Ivantsiv, D Kornitzer, D Raveh

Author Affiliations

1: Life Sciences Department, Ben Gurion University of the Negev, Box 653, Beersheba 84105, Israel.

Articles citing this

Genome-wide occupancy profile of the RNA polymerase III machinery in Saccharomyces cerevisiae reveals loci with incomplete transcription complexes. Mol Cell Biol (2004) 2.13

Rad6 plays a role in transcriptional activation through ubiquitylation of histone H2B. Genes Dev (2004) 2.04

Molecular dissection of mitotic recombination in the yeast Saccharomyces cerevisiae. Mol Cell Biol (2003) 1.83

Replicon dynamics, dormant origin firing, and terminal fork integrity after double-strand break formation. Cell (2009) 1.78

The DNA damage-inducible UbL-UbA protein Ddi1 participates in Mec1-mediated degradation of Ho endonuclease. Mol Cell Biol (2005) 1.30

Characterization of mutations that are synthetic lethal with pol3-13, a mutated allele of DNA polymerase delta in Saccharomyces cerevisiae. Curr Genet (2003) 1.21

Regulation of repair choice: Cdk1 suppresses recruitment of end joining factors at DNA breaks. DNA Repair (Amst) (2009) 1.09

Unique role for the UbL-UbA protein Ddi1 in turnover of SCFUfo1 complexes. Mol Cell Biol (2006) 1.09

The dynamics of homologous pairing during mating type interconversion in budding yeast. PLoS Genet (2006) 1.07

Degradation or maintenance: actions of the ubiquitin system on eukaryotic chromatin. Eukaryot Cell (2002) 1.00

Sequestration of highly expressed mRNAs in cytoplasmic granules, P-bodies, and stress granules enhances cell viability. PLoS Genet (2012) 1.00

DNA-damage-inducible 1 protein (Ddi1) contains an uncharacteristic ubiquitin-like domain that binds ubiquitin. Structure (2015) 0.92

SCFCdc4 enables mating type switching in yeast by cyclin-dependent kinase-mediated elimination of the Ash1 transcriptional repressor. Mol Cell Biol (2010) 0.88

Homology modeling and mutational analysis of Ho endonuclease of yeast. Genetics (2004) 0.84

Elevating the level of Cdc34/Ubc3 ubiquitin-conjugating enzyme in mitosis inhibits association of CENP-E with kinetochores and blocks the metaphase alignment of chromosomes. J Cell Biol (2001) 0.82

Nuclear export of Ho endonuclease of yeast via Msn5. Curr Genet (2008) 0.80

Transfer of Ho endonuclease and Ufo1 to the proteasome by the UbL-UbA shuttle protein, Ddi1, analysed by complex formation in vitro. PLoS One (2012) 0.80

Overhang polarity of chromosomal double-strand breaks impacts kinetics and fidelity of yeast non-homologous end joining. Nucleic Acids Res (2016) 0.78

Fidelity of end joining in mammalian episomes and the impact of Metnase on joint processing. BMC Mol Biol (2014) 0.77

Structural studies of the yeast DNA damage-inducible protein Ddi1 reveal domain architecture of this eukaryotic protein family. Sci Rep (2016) 0.75

Articles cited by this

The ubiquitin system. Annu Rev Biochem (1998) 43.36

Checkpoints: controls that ensure the order of cell cycle events. Science (1989) 21.01

Cell cycle checkpoints: preventing an identity crisis. Science (1996) 13.74

F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell (1997) 11.62

SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell (1996) 11.22

Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem (1996) 10.70

PEST sequences and regulation by proteolysis. Trends Biochem Sci (1996) 8.90

Regulation of RAD53 by the ATM-like kinases MEC1 and TEL1 in yeast cell cycle checkpoint pathways. Science (1996) 8.71

How proteolysis drives the cell cycle. Science (1996) 8.59

Mitotic checkpoint genes in budding yeast and the dependence of mitosis on DNA replication and repair. Genes Dev (1994) 8.53

The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science (1999) 7.60

RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc Natl Acad Sci U S A (1999) 7.32

Homothallic switching of yeast mating type cassettes is initiated by a double-stranded cut in the MAT locus. Cell (1982) 7.00

Ordered recruitment of transcription and chromatin remodeling factors to a cell cycle- and developmentally regulated promoter. Cell (1999) 6.83

Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair. Cell (1999) 6.56

A checkpoint regulates the rate of progression through S phase in S. cerevisiae in response to DNA damage. Cell (1995) 6.00

A set of vectors with a tetracycline-regulatable promoter system for modulated gene expression in Saccharomyces cerevisiae. Yeast (1997) 5.95

Cell cycle control of the yeast HO gene: cis- and trans-acting regulators. Cell (1987) 5.12

Multiple ubiquitin-conjugating enzymes participate in the in vivo degradation of the yeast MAT alpha 2 repressor. Cell (1993) 5.05

Homing endonucleases: keeping the house in order. Nucleic Acids Res (1997) 5.03

Spk1/Rad53 is regulated by Mec1-dependent protein phosphorylation in DNA replication and damage checkpoint pathways. Genes Dev (1996) 4.98

Control of cell type in yeast by the mating type locus. The alpha 1-alpha 2 hypothesis. J Mol Biol (1981) 4.87

The N-end rule. Cell (1992) 4.80

The yeast cell cycle gene CDC34 encodes a ubiquitin-conjugating enzyme. Science (1988) 4.69

Control of the DNA damage checkpoint by chk1 and rad53 protein kinases through distinct mechanisms. Science (1999) 4.61

Global response of Saccharomyces cerevisiae to an alkylating agent. Proc Natl Acad Sci U S A (1999) 4.27

Cdc53/cullin and the essential Hrt1 RING-H2 subunit of SCF define a ubiquitin ligase module that activates the E2 enzyme Cdc34. Genes Dev (1999) 4.17

Cdc53 is a scaffold protein for multiple Cdc34/Skp1/F-box proteincomplexes that regulate cell division and methionine biosynthesis in yeast. Genes Dev (1998) 3.91

Regulated degradation of the transcription factor Gcn4. EMBO J (1994) 3.64

A ubiquitin mutant with specific defects in DNA repair and multiubiquitination. Mol Cell Biol (1995) 3.56

The Cdc4/34/53 pathway targets Cdc6p for proteolysis in budding yeast. EMBO J (1997) 3.35

Identification of a family of human F-box proteins. Curr Biol (1999) 3.31

Yeast DNA repair proteins Rad6 and Rad18 form a heterodimer that has ubiquitin conjugating, DNA binding, and ATP hydrolytic activities. J Biol Chem (1997) 3.11

Cdc7p-Dbf4p kinase binds to chromatin during S phase and is regulated by both the APC and the RAD53 checkpoint pathway. EMBO J (1999) 3.03

Negative regulation of FAR1 at the Start of the yeast cell cycle. Genes Dev (1993) 2.89

RAD9, RAD17, and RAD24 are required for S phase regulation in Saccharomyces cerevisiae in response to DNA damage. Genetics (1997) 2.84

Active site mutants in the six regulatory particle ATPases reveal multiple roles for ATP in the proteasome. EMBO J (1998) 2.82

Phosphorylation- and ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor Far1p in budding yeast. Genes Dev (1997) 2.77

Analysis of Rad3 and Chk1 protein kinases defines different checkpoint responses. EMBO J (1998) 2.32

DNA damage checkpoint in budding yeast. EMBO J (1998) 2.25

ATM: a mediator of multiple responses to genotoxic stress. Oncogene (1999) 2.06

The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme. Proc Natl Acad Sci U S A (1998) 2.05

RAD53, DUN1 and PDS1 define two parallel G2/M checkpoint pathways in budding yeast. EMBO J (1999) 2.05

MMS2, encoding a ubiquitin-conjugating-enzyme-like protein, is a member of the yeast error-free postreplication repair pathway. Proc Natl Acad Sci U S A (1998) 1.94

Pds1p of budding yeast has dual roles: inhibition of anaphase initiation and regulation of mitotic exit. Genes Dev (1999) 1.79

Cell cycle regulation by the ubiquitin pathway. FASEB J (1997) 1.73

A family of cyclin-like proteins that interact with the Pho85 cyclin-dependent kinase. Mol Cell Biol (1997) 1.72

Degradation of the transcription factor Gcn4 requires the kinase Pho85 and the SCF(CDC4) ubiquitin-ligase complex. Mol Biol Cell (2000) 1.71

Domains required for dimerization of yeast Rad6 ubiquitin-conjugating enzyme and Rad18 DNA binding protein. Mol Cell Biol (1997) 1.64

Cdk7 is essential for mitosis and for in vivo Cdk-activating kinase activity. Genes Dev (1998) 1.62

Cell cycle progression in the presence of irreparable DNA damage is controlled by a Mec1- and Rad53-dependent checkpoint in budding yeast. EMBO J (1999) 1.50

Cak1 is required for Kin28 phosphorylation and activation in vivo. Mol Cell Biol (1998) 1.39

The Blocks database--a system for protein classification. Nucleic Acids Res (1996) 1.38

Human Cdc34 and Rad6B ubiquitin-conjugating enzymes target repressors of cyclic AMP-induced transcription for proteolysis. Mol Cell Biol (1999) 1.24

An essential function of Grr1 for the degradation of Cln2 is to act as a binding core that links Cln2 to Skp1. J Cell Sci (1998) 1.16

Articles by these authors

The yeast nuclear import receptor is required for mitosis. Proc Natl Acad Sci U S A (1995) 2.23

Degradation of the transcription factor Gcn4 requires the kinase Pho85 and the SCF(CDC4) ubiquitin-ligase complex. Mol Biol Cell (2000) 1.71

Adult patients with occult bacteremia discharged from the emergency department: epidemiological and clinical characteristics. Clin Infect Dis (2001) 1.50

Alternative mRNA structures of the cIII gene of bacteriophage lambda determine the rate of its translation initiation. J Mol Biol (1989) 1.44

Klebsiella bacteraemia: community versus nosocomial infection. QJM (1996) 1.35

Cost-effectiveness of blood cultures for adult patients with cellulitis. Clin Infect Dis (1999) 1.29

The risk of vascular infection in adult patients with nontyphi Salmonella bacteremia. Am J Med (2001) 1.23

The three vessels and trachea view (3VT) in fetal cardiac scanning. Ultrasound Obstet Gynecol (2002) 1.17

Carriage rate of carbapenem-resistant Klebsiella pneumoniae in hospitalised patients during a national outbreak. J Hosp Infect (2009) 1.12

Targeting a truncated Ho-endonuclease of yeast to novel DNA sites with foreign zinc fingers. Nucleic Acids Res (1998) 1.12

The high copper tolerance of Candida albicans is mediated by a P-type ATPase. Proc Natl Acad Sci U S A (2000) 1.11

Prevalence and predictive features of bacteremic urinary tract infection in emergency department patients. Eur J Clin Microbiol Infect Dis (2007) 1.09

Clinical characteristics of patients with psoas abscess due to non-typhi Salmonella. Eur J Clin Microbiol Infect Dis (2003) 1.09

A highly polymorphic degenerate microsatellite for molecular strain typing of Candida krusei. Microbiology (2001) 1.07

Age as a risk factor for severe Plasmodium falciparum malaria in nonimmune patients. Clin Infect Dis (2001) 1.04

In vitro culture of tobacco protoplasts: use of feeder techniques to support division of cells plated at low densities. In Vitro (1974) 1.01

Surveillance of antimicrobial prophylaxis for surgical procedures. Infect Control Hosp Epidemiol (1999) 1.00

Identification of the heterothallic mutation in HO-endonuclease of S. cerevisiae using HO/ho chimeric genes. Curr Genet (1995) 0.98

Functional and structural elements of the mRNA of the cIII gene of bacteriophage lambda. J Mol Biol (1991) 0.96

Changing epidemiology of infective endocarditis: a retrospective survey of 108 cases, 1990-1999. Eur J Clin Microbiol Infect Dis (2002) 0.94

The prevalence of hepatitis A antibodies among Israeli travellers and the economic feasibility of screening before vaccination. Int J Epidemiol (1998) 0.94

Prospective hospital-wide studies of 505 patients with nosocomial bacteraemia in 1997 and 2002. J Hosp Infect (2005) 0.92

Murine macrophage mannose receptor promoter is regulated by the transcription factors PU.1 and SP1. Blood (1997) 0.91

Prospective surveillance of vancomycin-resistant enterococci in a neonatal intensive care unit. Eur J Clin Microbiol Infect Dis (2000) 0.91

Non-Typhi Salmonella gastroenteritis in children presenting to the emergency department: characteristics of patients with associated bacteraemia. Clin Microbiol Infect (2005) 0.90

A week-by-week analysis of the low-risk criteria for serious bacterial infection in febrile neonates. Arch Dis Child (2008) 0.89

Comparison of peritoneal fluid culture results from adults and children undergoing CAPD. Perit Dial Int (1999) 0.89

Urine polymerase chain reaction as a screening tool for the detection of congenital cytomegalovirus infection. Arch Dis Child Fetal Neonatal Ed (2003) 0.86

Cell-mediated mutagenesis and tumor-initiating activity of the ubiquitous polycyclic hydrocarbon, cyclopenta[c,d]pyrene. Carcinogenesis (1982) 0.86

Posttranscriptional control of the lysogenic pathway in bacteriophage lambda. Prog Nucleic Acid Res Mol Biol (1993) 0.85

Nosocomial coagulase-negative staphylococcal infections in bone marrow transplantation recipients with central vein catheter. A 5-year prospective study. Transplantation (1996) 0.83

Lovastatin and elevated creatine kinase: results of rechallenge. Lancet (1989) 0.83

Cloning and restriction analysis of ribosomal RNA genes from Mycobacterium smegmatis. FEMS Microbiol Lett (1989) 0.83

Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae. Infection (2006) 0.83

Puerperal adrenal abscess complicating chorioamnionitis. Obstet Gynecol (2002) 0.82

Shigella sonnei myocarditis. Clin Cardiol (1987) 0.82

Assessment of knowledge of guidelines for the prevention of infective endocarditis amongst clinicians in a teaching hospital. J Hosp Infect (2000) 0.81

In-vitro activity of cefepime and other broad-spectrum antimicrobials against several groups of gram-negative bacilli and Staphylococcus aureus. Diagn Microbiol Infect Dis (1999) 0.81

Cell specificity in metabolic activation of aflatoxin B1 and benzo(a)pyrene to mutagens for mammalian cells. Nature (1978) 0.81

Self-retaining T-incision for difficult tracheotomy. J Laryngol Otol (2007) 0.81

Diagnostic value of the D-dimer test in deep vein thrombosis: improved results by a new assay method and by using discriminate levels. Thromb Res (2001) 0.80

Identification of a positive regulator of the cell cycle ubiquitin-conjugating enzyme Cdc34 (Ubc3). Mol Cell Biol (1996) 0.79

Q fever endocarditis; not always expected. Clin Microbiol Infect (2009) 0.79

Detection of guinea pig cytomegalovirus nucleic acids in cultured cells with biotin-labelled hybridization probes. Virus Res (1987) 0.79

Ventilation and clearance of the middle ear. J Laryngol Otol (2009) 0.79

Clinical and demographic characteristics of elderly patients hospitalised in an internal medicine department in Israel. Int J Clin Pract (2007) 0.78

Poor prenatal detection rate of cardiac anomalies in Noonan syndrome. Ultrasound Obstet Gynecol (2002) 0.78

Tetracycline derivatives, alternative treatment for nocardiosis in transplanted patients. Clin Nephrol (1997) 0.78

Extreme leukocytosis in the emergency department. QJM (2007) 0.78

Enhanced anticoagulant effect of acenocoumarol induced by amiodarone coadministration. Isr J Med Sci (1988) 0.77

Oral tuberculosis following autologous bone marrow transplantation for Hodgkin's disease with interleukin-2 and alpha-interferon immunotherapy. Bone Marrow Transplant (1996) 0.77

Separation of human lymphocytes on Ficoll-Paque gradients: stimulation of cells and depletion of a concanavalin-A responsive radioresistant subpopulation. Radiat Res (1983) 0.77

Glycogen metabolism and the nuclear envelope-annulate lamella system in the early chick embryo. J Cell Sci (1985) 0.77

Legionella feeleii pneumonia and pericarditis. J Infect (1997) 0.77

Group A streptococcus bacteraemia: comparison of adults and children in a single medical centre. Clin Microbiol Infect (2006) 0.76

Erythropoietin deficiency causes anemia in nephrotic children with normal kidney function. Am J Kidney Dis (2001) 0.76

Procalcitonin in the elderly: normal plasma concentrations and response to bacterial infections. Eur J Clin Microbiol Infect Dis (2005) 0.75

Improving implementation of infection control guidelines to reduce nosocomial infection rates: pioneering the report card. J Hosp Infect (2012) 0.75

Sexual behavior of homosexual and bisexual men attending an HIV testing clinic in Jerusalem 1986/7-1990. Isr J Psychiatry Relat Sci (1993) 0.75

Glycogen metabolism in the prelaid chick embryo. J Morphol (1979) 0.75

Safety of once-daily aminoglycosides in older people. J Am Geriatr Soc (2000) 0.75

Thymoma presenting as a superior vena cava syndrome remission following therapy. Klin Wochenschr (1987) 0.75

Emergence of drug-resistant tuberculosis in Jerusalem: ten-year retrospective review. Isr J Med Sci (1997) 0.75

Ornithodoros tholozani bites: a unique clinical picture. J Am Acad Dermatol (1992) 0.75

Vitamin E deficiency and peripheral edema. Ann Intern Med (1989) 0.75

Translation control of gene expression. J Basic Clin Physiol Pharmacol (1992) 0.75

Quinidine-induced uveitis. Isr J Med Sci (1992) 0.75

Practical guidelines for vancomycin usage, with prospective drug-utilization evaluation. Infect Control Hosp Epidemiol (2000) 0.75

A tool for enhancing site-specific gene integration in mammalian cells. Adv Exp Med Biol (1998) 0.75

Outbreak of Q fever among kitchen employees in an urban hospital. Eur J Clin Microbiol Infect Dis (2001) 0.75

Nucleolar ontogenesis in the uterine chick germ correlated with morphogenetic events. Exp Cell Res (1976) 0.75

A microtiter plate assay for the selection of 6-thioguanine-resistant mutants in Chinese hamster V79 cells in the presence of phorbol-12-myristate-13-acetate. Mutat Res (1983) 0.75

[Primary familial hyper-alpha-lipoproteinemia in Israel]. Harefuah (1986) 0.75

The synaptonemal complex as part of the nuclear matrix of the flour moth, Ephestia kuehniella. Exp Cell Res (1984) 0.75

Incidence of immunoglobulin G antibodies to Chlamydia pneumoniae in acute myocardial infarction patients. Isr Med Assoc J (2001) 0.75

Ganciclovir for the treatment of disseminated CMV disease without pneumonia in allogeneic T-lymphocyte depleted bone marrow transplantation. Leuk Lymphoma (1993) 0.75